Significance of human β-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections  S. Yanagi, J. Ashitani,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Patterns of delays in diagnosis amongst patients with smear-positive pulmonary tuberculosis at a teaching hospital in Turkey  E. Okur, A. Yilmaz, A. Saygi,
L. Boyanova  Clinical Microbiology and Infection 
Sputum colour reported by patients is not a reliable marker of the presence of bacteria in acute exacerbations of chronic obstructive pulmonary disease 
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients  R. Cantón, N. Cobos,
Gut bacterial microbiota and obesity
R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz 
Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.
Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis  T. Steinmetz, N.
Herpes zoster in non-hospitalized children
Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
R. Cantón  Clinical Microbiology and Infection 
Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications 
Genital Chlamydia trachomatis infections
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Evaluation of viral co-infections in hospitalized and non-hospitalized children with respiratory infections using microarrays  S. Kouni, P. Karakitsos,
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription  B. Maraha, M. Bonten, H. Fiolet,
Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain  J.-M. Aguado, C. Lumbreras, D.
Vector control: a cornerstone in the malaria elimination campaign
A. Oliver, A. Mena  Clinical Microbiology and Infection 
Training for the infectious diseases speciality in Norway
B. Gordts  Clinical Microbiology and Infection 
CMI editorial report 2011 Clinical Microbiology and Infection
P.M. Keig, E. Ingham, P.A.R. Vandamme, K.G. Kerr 
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
Elements of design: the knowledge on which we build
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β- lactamase-producing clone with a heterogeneous carbapenem resistance.
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Metagenomics and probiotics
W.A. Craig  Clinical Microbiology and Infection 
J. Garau  Clinical Microbiology and Infection 
Antibacterial drug discovery in the 21st century
Newly identified respiratory viruses associated with acute lower respiratory tract infections in children in Lanzou, China, from 2006 to 2009  Y. Jin,
Abstracts cont. Clinical Microbiology and Infection
Current experience in treating invasive zygomycosis with posaconazole
Vaccinations against respiratory tract infections at Hajj
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Ethan Rubinstein, Itzhak Levy  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin  G. Drusano  Clinical Microbiology and Infection 
P. Kaltsas, S. Want, J. Cohen  Clinical Microbiology and Infection 
Overview of cefixime use in community-acquired infections
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
C.P. Kelly  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Genomic diversity of group A rotavirus strains in patients aged 1–36 months admitted for acute watery diarrhoea in northern India: a hospital-based study 
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Serum ferritin levels in West Nile encephalitis
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Significance of human β-defensins in the epithelial lining fluid of patients with chronic lower respiratory tract infections  S. Yanagi, J. Ashitani, K. Imai, Y. Kyoraku, A. Sano, N. Matsumoto, M. Nakazato  Clinical Microbiology and Infection  Volume 13, Issue 1, Pages 63-69 (January 2007) DOI: 10.1111/j.1469-0691.2006.01574.x Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Human β-defensin (hBD) concentrations in serum from healthy volunteers (HV), patients with idiopathic pulmonary fibrosis (IPF) and patients with chronic lower respiratory tract infection (CRI). In the CRI group, open circles indicate patients infected with a mucoid strain of Pseudomonas aeruginosa, and closed circles indicate patients infected with a non-mucoid phenotype of P. aeruginosa. Clinical Microbiology and Infection 2007 13, 63-69DOI: (10.1111/j.1469-0691.2006.01574.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Human β-defensin (hBD) concentrations in epithelial lining fluid from healthy volunteers (HV), patients with idiopathic pulmonary fibrosis (IPF) and patients with chronic lower respiratory tract infection (CRI). In the CRI group, open circles indicate patients infected with a mucoid phenotype of Pseudomonas aeruginosa, and closed circles indicate patients infected with a non-mucoid phenotype of P. aeruginosa. Clinical Microbiology and Infection 2007 13, 63-69DOI: (10.1111/j.1469-0691.2006.01574.x) Copyright © 2007 European Society of Clinical Infectious Diseases Terms and Conditions